NCT06698926View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Healthy Volunteer
Interventions
DRUG

ABBV-CLS-616

Oral Tablet

DRUG

Placebo

Oral Tablet

DRUG

Itraconazole

Oral Capsule

Trial Locations (1)

60030

RECRUITING

Acpru /Id# 270532, Grayslake

Sponsors

Lead Sponsor

AbbVie

Collaborators (1)

Calico Life Sciences LLC
All Listed Sponsors
collaborator

Calico Life Sciences LLC

INDUSTRY

lead

AbbVie

INDUSTRY